BLUFFDALE, Utah, April 29, 2021 /CNW/ — Med7, LLC (www.Med7cbd.com) and HempCo, Inc. announce the completion of a human clinical study in patients with Type II Diabetes using Purzorb® technology, now trademarked as Hempzorb81TM. “This study will provide our customers and providers with evidence based products not seen to this point in the Industrial Hemp and CBD market place,” said Matt Smith, CEO of Med7. This study was done with support from the National Institutes of Health (NIH) as part of their small business grant program.
[Read more…] about Med 7 llc, announce the completion of a safety and efficacy study using hempzorb81™ full spectrum oil in patients with type ii diabetesCOVID-19 Update
COVID-19 Update
by Med 7 | March 23, 2020
Thank you for the trust you place in us and our products.
I want to personally update you on the situation with COVID-19 (the coronavirus) and the steps we are taking to ensure your health and safety with our products and supply.
Since 2014, the Med 7 team has been working hard to ensure the quality, supply and safety of Full Spectrum Hemp products. As a global company, we have strong relationships in place with health experts and both local and international regulatory authorities worldwide. We go through regular inspections and are in constant contact with them to make sure our policies and procedures meet or exceed their guidelines.
Product quality and innovation is our lifeblood. We follow strict cGMP procedures in our manufacturing process which includes strict health procedures with our employees and vendors. Every ingredient is tested and verified prior to production and then tested again prior to being released for sale. All our employees are required to stay home if they are sick. We have followed this strictly before the COVID-19 outbreak and will continue to do so when this pandemic is over. We are committed to continuing to improve on these quality and safety procedures so that we can learn and prepare for events like we are experiencing.
We routinely stock up our raw ingredient/component supply at the beginning of the year so inventory will not be a concern in the coming months. We are committed to make sure the supply and delivery of your Med 7 products are uninterrupted. We understand that in today’s world, supply of health and wellness products are fundamental to our lives, which is why it can’t – and shouldn’t – simply stop. For those of you who are stocking up with a safety supply or extra bottles for friends and family, please be assured that we will fulfill these orders.
Thank you for your continued trust and support of Med 7. We look forward to serving you throughout the coming months and years.
Sincerely,
Matt Smith, CEO PurHealthRX
PurHealthRX® Announces Completion of the First Major Non-pharmaceutical CBD Study in Humans
LAS VEGAS, NV – PurHealthRX® announced the completion of the first major clinical study looking at the anti-aging effects and safety of full spectrum hemp CBD oil in human subjects. The study was completed with support from the National Institute of Health (NIH).
The randomized placebo-controlled study on 150 patients showed that full spectrum hemp CBD oil had a significant effect on a multitude of anti-aging related factors.
The study looked at inflammation markers, cardiovascular and metabolism indicators while also tracking anxiety and sleep.
“We are very pleased that our Purzorb® formulation of full spectrum hemp CBD oil showed such a strong effect in these anti-aging factors,” said Matt Smith, CEO.
“Inflammation and cardiovascular problems are part of the aging process. By showing a significant effect on so many of these factors, there is strong evidence that the endocannabinoid system plays a significant role in the anti-aging process,” Smith said.
According to Smith, this is the first non-pharmaceutical study demonstrating both the safety and efficacy of naturally occurring cannabinoids such as CBD.
PurHealthRX® scientists have been working on methods to deliver naturally occurring cannabinoids since 2014. “Working with industrial hemp since the 2014 Farm Bill passed has given us a great understanding of the problems that face this market,” Smith explained.
“The inconsistencies, impurities and no standardization, coupled with a lack of clinical data, has created a lot of confusion with consumers who could really benefit from CBD products,” Smith said.
The study looked at inflammatory markers such as Tumor Necrosis Factor Alpha, Interleukin 6, C-Reactive Protein and NF-κB. Metabolism and cardiovascular indicators such as HA1c, LDL/HDL and Homocysteine levels were also measured. One of the significant findings was that the HA1c levels dropped by an average of almost one point in the test subjects.
About PurHealthRX®
PurHealthRX® is a technology-driven health and wellness company that manufactures, distributes and sells full spectrum hemp CBD oil products using Purzorb®, a proprietary technology that mimics the body’s natural process of absorption by converting oil-based nutrients into water-soluble products. Purzorb® products are sold under the Med 7® and Pur 7® brands, and marketed as Biosorb™ in products sold through Q Sciences.
PurHealthRX, LLC
601 E. Charleston Blvd Suite 100
Las Vegas, NV 89104
877-259-6887
purhealthrx.com